NewEdge Wealth’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.69M | Sell |
34,572
-23,089
| -40% | -$1.13M | 0.03% | 415 |
|
|
2025
Q1 | $4M | Buy |
57,661
+16,887
| +41% | +$1.17M | 0.07% | 225 |
|
|
2024
Q4 | $3.51M | Sell |
40,774
-6,769
| -14% | -$582K | 0.06% | 246 |
|
|
2024
Q3 | $5.66M | Buy |
47,543
+6,564
| +16% | +$782K | 0.1% | 173 |
|
|
2024
Q2 | $5.85M | Sell |
40,979
-433
| -1% | -$61.8K | 0.13% | 142 |
|
|
2024
Q1 | $5.14M | Buy |
41,412
+12,283
| +42% | +$1.52M | 0.12% | 159 |
|
|
2023
Q4 | $3.01M | Sell |
29,129
-962
| -3% | -$99.5K | 0.08% | 224 |
|
|
2023
Q3 | $2.74M | Buy |
30,091
+515
| +2% | +$46.8K | 0.09% | 204 |
|
|
2023
Q2 | $2.39M | Buy |
29,576
+60
| +0.2% | +$4.86K | 0.08% | 217 |
|
|
2023
Q1 | $2.35M | Sell |
29,516
-3,790
| -11% | -$302K | 0.09% | 197 |
|
|
2022
Q4 | $2.25M | Sell |
33,306
-514
| -2% | -$34.8K | 0.1% | 198 |
|
|
2022
Q3 | $1.69M | Sell |
33,820
-1,096
| -3% | -$54.6K | 0.08% | 211 |
|
|
2022
Q2 | $1.95M | Buy |
34,916
+27,332
| +360% | +$1.52M | 0.09% | 195 |
|
|
2022
Q1 | $421K | Sell |
7,584
-2,408
| -24% | -$134K | 0.02% | 324 |
|
|
2021
Q4 | $559K | Sell |
9,992
-312
| -3% | -$17.5K | 0.02% | 283 |
|
|
2021
Q3 | $495K | Buy |
10,304
+1,360
| +15% | +$65.3K | 0.03% | 219 |
|
|
2021
Q2 | $375K | Buy |
8,944
+1,282
| +17% | +$53.8K | 0.03% | 227 |
|
|
2021
Q1 | $258K | Buy |
+7,662
| New | +$258K | 0.03% | 264 |
|